How Much Does Provigil (Modafinil) Cost in Utah in 2026?

Brand Provigil vs. Generic Modafinil: The Price Gap in Utah

The difference between brand Provigil and its generic equivalent remains enormous. Brand-name Provigil, manufactured by Cephalon (now a Teva subsidiary), carries a list price of roughly $850 per month for a standard 200 mg daily supply. Generic modafinil, available from multiple manufacturers since patent expiration in 2012, averages about $80 per month at Utah retail pharmacies when paying cash.

That price drop exceeds 90%. The FDA's Orange Book lists several approved generic modafinil products rated as therapeutically equivalent (AB-rated) to brand Provigil. These generics contain the same active ingredient at the same dose and must meet identical bioequivalence standards under 21 CFR 320. Utah pharmacies routinely dispense generic modafinil unless a prescriber writes "brand medically necessary" on the prescription, which is rare.

Prices can vary by $20 to $40 between pharmacies within the same Utah metro area. Checking prices at independent pharmacies in Salt Lake City, Provo, and Ogden before filling a prescription is a practical first step. Pharmacy discount tools (GoodRx, RxSaver, SingleCare) often bring the cash price for generic modafinil below $30 for a 30-tablet supply at select Utah locations, though these prices shift monthly.

Utah Medicaid Does Not Cover Provigil

Utah Medicaid, administered through the Utah Department of Health and Human Services, does not include Provigil or generic modafinil on its preferred drug list. This applies to both brand and generic formulations.

Medicaid formulary exclusions for wakefulness-promoting agents are common across states. The Centers for Medicare & Medicaid Services allows state Medicaid programs latitude in covering or excluding Schedule IV stimulants. Utah has exercised that option by omitting modafinil entirely. Beneficiaries who receive a modafinil prescription will face a claim denial at the pharmacy counter.

A prior authorization request may be submitted by a prescriber, but approval rates for modafinil under Utah Medicaid are extremely low. The program generally requires documented failure of behavioral interventions and, for narcolepsy, evidence that alternative covered medications (such as sodium oxybate or certain stimulants) were tried first. Prescribers should contact the Utah Medicaid pharmacy help desk at 1-800-662-9651 for the most current prior authorization criteria.

For Utah residents on Medicaid who have a confirmed narcolepsy diagnosis, the American Academy of Sleep Medicine clinical practice guidelines recommend modafinil as a first-line treatment. The disconnect between clinical guidelines and Medicaid coverage creates a real access barrier. Patients in this situation should ask their sleep specialist to initiate the prior authorization process with supporting polysomnography and MSLT documentation.

What Insurance Plans in Utah Cover Modafinil?

Most commercial insurance plans available on the Utah Health Insurance Marketplace and through employer-sponsored coverage do include generic modafinil, typically on a Tier 2 or Tier 3 formulary position. Brand Provigil, when covered at all, usually sits on a specialty or non-preferred tier with copays exceeding $200 per month.

Coverage specifics vary by plan. SelectHealth, the largest Utah-based insurer, generally covers generic modafinil with prior authorization for FDA-approved indications: narcolepsy, obstructive sleep apnea (as an adjunct to CPAP), and shift work disorder. The prior authorization typically requires a confirmed diagnosis and documentation that the condition affects daily functioning.

PEHP (Public Employees Health Program), which covers Utah state employees, also lists generic modafinil but requires step therapy documentation. Blue Cross Blue Shield of Utah plans and Regence BlueCross BlueShield plans sold in Utah follow similar patterns: generic modafinil is accessible after prior authorization, while brand Provigil is excluded or requires a formulary exception.

A practical checklist for Utah residents checking their coverage:

1. Log in to your insurer's formulary search tool and enter "modafinil."
2. Note the tier placement and whether prior authorization is required.
3. Ask your prescriber to submit the PA before you arrive at the pharmacy.
4. If denied, request a formulary exception with clinical documentation.
5. Compare your insurance copay to the cash-pay generic price. Sometimes cash is cheaper.

The Endocrine Society's 2020 clinical practice guideline on pharmacological management notes that wakefulness-promoting agents like modafinil may be used off-label for fatigue related to endocrine disorders, but off-label uses are rarely covered by insurance in Utah without extensive appeals.

Compounded Modafinil in Utah: Legal and Available via 503A Pharmacies

Compounded modafinil is legal in Utah when prepared by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits pharmacies to compound medications for individual patients when a prescriber determines a medical need, such as a patient who cannot swallow standard tablets or requires a non-standard dose.

Utah's compounding pharmacy regulations align with federal 503A requirements. The Utah Division of Occupational and Professional Licensing (DOPL) oversees pharmacy practice in the state and requires compounding pharmacies to maintain proper licensure. Modafinil is a Schedule IV controlled substance, so compounding pharmacies must also hold a valid DEA registration and comply with Utah Controlled Substances Act provisions.

Pricing for compounded modafinil varies by pharmacy and formulation but can be competitive with, or in some cases lower than, commercial generic pricing. Some compounding pharmacies in the Salt Lake City metro area offer modafinil preparations at reduced cost when purchased through a subscription or membership model.

One caution: compounded medications do not undergo the same FDA approval process as manufactured generics. The FDA's guidance on compounding makes clear that 503A compounded drugs are not evaluated for safety, efficacy, or manufacturing consistency in the way that approved products are. Patients should verify that their compounding pharmacy is accredited by the Pharmacy Compounding Accreditation Board (PCAB) or holds state inspection records demonstrating compliance with USP 795 and USP 800 standards.

Getting Modafinil via Telehealth in Utah

Utah permits telehealth prescribing of modafinil. The state updated its telehealth parity laws (Utah Code § 26-60) to require insurers to cover telehealth visits on par with in-person visits, which includes the prescribing of Schedule IV controlled substances when a valid patient-provider relationship is established.

The DEA's updated telehealth prescribing rule allows prescribers with a valid DEA registration to issue modafinil prescriptions after a telehealth evaluation, provided they comply with both federal and state requirements. Utah does not impose additional restrictions beyond federal standards for Schedule IV telehealth prescribing.

This matters for cost. Telehealth visits typically range from $50 to $150 for an initial consultation, compared to $200 to $400 for an in-person sleep medicine appointment without insurance. For Utah residents in rural areas (St. George, Logan, Vernal, or the Uintah Basin), telehealth eliminates travel time and cost that can be substantial.

Several telehealth platforms operating in Utah can evaluate patients for narcolepsy, shift work disorder, or obstructive sleep apnea and prescribe modafinil when clinically appropriate. The prescription can be sent electronically to any Utah retail or mail-order pharmacy. Patients should confirm that the telehealth provider is licensed in Utah and that the platform uses EPCS (Electronic Prescribing for Controlled Substances) compliant software.

How Modafinil Works: The Clinical Evidence

Modafinil promotes wakefulness through a mechanism that is not fully characterized but is distinct from traditional amphetamine-type stimulants. Research indicates it increases dopamine concentrations by inhibiting the dopamine transporter (DAT), with additional effects on norepinephrine, histamine, and orexin pathways in the hypothalamus [1].

The key trial leading to FDA approval was the US Modafinil in Narcolepsy Multicenter Study Group trial, published in the Annals of Neurology in 1998. This randomized, double-blind, placebo-controlled study (N=283) demonstrated that modafinil 200 mg and 400 mg significantly improved objective wakefulness on the Maintenance of Wakefulness Test (MWT) compared to placebo (P<0.001 for both doses) [1]. Patients also reported significant reductions in excessive daytime sleepiness on the Epworth Sleepiness Scale.

A subsequent Cochrane systematic review of modafinil for narcolepsy, published in the Cochrane Library, confirmed moderate-quality evidence supporting modafinil's efficacy for reducing daytime sleepiness, with a mean improvement of approximately 2.5 points on the ESS compared to placebo [2].

For shift work disorder, a randomized trial by Czeisler et al. (N=209) published in the New England Journal of Medicine found that modafinil 200 mg reduced excessive sleepiness during night shifts and modestly improved performance on neurobehavioral testing [3]. The clinical effect was statistically significant but moderate in magnitude.

Dr. Charles Czeisler, Chief of the Division of Sleep and Circadian Disorders at Brigham and Women's Hospital, stated in the NEJM trial publication: "Modafinil significantly reduced the extreme sleepiness that afflicted patients with shift work sleep disorder and resulted in a small but significant improvement in performance" [3].

The FDA-approved prescribing information for Provigil lists the recommended dose as 200 mg taken once daily in the morning for narcolepsy and obstructive sleep apnea, or approximately one hour before the start of a work shift for shift work disorder. Doses above 200 mg daily have not shown additional benefit in clinical trials [4].

Side Effects and Safety Considerations

Common adverse effects reported in clinical trials include headache (34% vs. 23% placebo), nausea (11% vs. 3%), nervousness (7% vs. 3%), and insomnia (5% vs. 1%), according to the Provigil prescribing label [4]. Most side effects are dose-dependent and resolve within the first two weeks.

Serious but rare adverse events include Stevens-Johnson syndrome (SJS) and drug reaction with eosinophilia and systemic symptoms (DRESS). The FDA added a boxed warning regarding serious dermatologic reactions. The estimated incidence of SJS with modafinil is approximately 1 to 6 cases per million patient-years based on post-marketing surveillance data reported to the FDA Adverse Event Reporting System [5].

Modafinil is a Schedule IV controlled substance with low abuse potential relative to Schedule II stimulants like amphetamine or methylphenidate. A study by Jasinski published in the Journal of Clinical Psychopharmacology found that modafinil produced subjective effects similar to methylphenidate at supratherapeutic doses but with lower reinforcing potential [6].

The American Academy of Sleep Medicine's 2021 clinical practice guideline for the treatment of central disorders of hypersomnolence states: "Modafinil/armodafinil is recommended as a treatment for daytime sleepiness in adults with narcolepsy" with a strong recommendation based on moderate-quality evidence [7].

Discount Programs and Savings Strategies for Utah Residents

No active manufacturer copay card exists specifically for generic modafinil, since Cephalon discontinued the brand Provigil copay program after genericization. Teva Pharmaceuticals, which acquired Cephalon, does not maintain a patient assistance program for modafinil generics.

Practical savings options for Utah residents include:

Pharmacy discount cards. GoodRx, RxSaver, and SingleCare frequently show generic modafinil 200 mg (30 tablets) priced between $25 and $45 at Utah pharmacies including Costco, Smith's, Walmart, and independent pharmacies. Costco Pharmacy in Salt Lake City, West Valley City, and Orem tends to offer consistently low cash prices and does not require a Costco membership for pharmacy purchases.

Mail-order pharmacies. Certified mail-order pharmacies, including those operating through pharmacy benefit managers like Express Scripts and CVS Caremark, may offer 90-day supplies at a lower per-unit cost. A 90-day supply of generic modafinil through mail order typically runs $70 to $120.

Patient assistance through NeedyMeds and RxAssist. These nonprofit databases aggregate discount programs. While modafinil-specific programs are limited, some manufacturer discount cards for other Teva generics may occasionally apply. Checking NeedyMeds periodically is worthwhile.

503A compounding. As noted above, some Utah compounding pharmacies offer modafinil at prices competitive with or below generic retail pricing, particularly for patients who establish ongoing relationships with the pharmacy.

For a Utah resident paying cash without insurance, the most cost-effective approach in 2026 is to use a pharmacy discount card at a high-volume retailer. The total monthly cost for generic modafinil 200 mg should be $25 to $45 at current pricing, well below the $80 average retail cash price and dramatically below the $850 brand list price. Confirm the price at the pharmacy counter before filling, as discount card prices can change week to week.